Sarepta Therapeutics (NASDAQ:SRPT) Rating Lowered to “Sector Perform” at Royal Bank of Canada
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was downgraded by stock analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating in a note issued to investors on Monday, MarketBeat Ratings reports. They presently have a $87.00 target price on the biotechnology company’s stock, down from their previous target price […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was downgraded by stock analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating in a note issued to investors on Monday, MarketBeat Ratings reports. They presently have a $87.00 target price on the biotechnology company’s stock, down from their previous target price […]
